Auxilium Biotechnologies has formally launched a scientific trial for its proprietary NeuroSpan Bridge, a nerve-regeneration implant first bioprinted in area. The implant, created utilizing the corporateās AMP-1 bioprinter aboard the Worldwide Area Station (ISS), is now being examined on sufferers with traumatic nerve accidents again on Earth.
This marks a serious second not only for Auxilium, however for bioprinting and regenerative drugs. Itās the primary time a tool made utilizing space-based bioprinting is being utilized in a scientific trial to assist restore motion and sensation in folks with extreme nerve harm.
NeuroSpan Bridge is a small implant designed to information nerve regeneration after harm. Surgeons place it contained in the physique on the website of the broken nerve, and the machine copies the pure construction of nerves utilizing tiny microchannels, which assist new nerve fibers develop in the precise course. Itās meant to hurry up therapeutic, cut back issues like continual ache, and enhance total restoration.
The trial, known as Neurospan-1, has enrolled the primary affected person within the US and goals to incorporate 80 contributors. It’s going down at a number of main medical facilities, together with New York College Langone, the College of California, San Francisco (UCSF), the Ohio State College Wexner Medical Middle, and the San Antonio Orthopaedic Group (TSAOG). The examine is concentrated on folks with traumatic nerve accidents, like these attributable to automobile accidents or office accidents, and can take a look at how properly the implant works, how protected it’s, and the way it compares to present therapies.
āWeāve spent years growing a know-how with the potential to alter lives, and as we speak, we’re one step nearer to creating {that a} actuality,ā stated Jacob Koffler, CEO of Auxilium.
From Orbit to Working Rooms
Probably the most hanging a part of the NeuroSpan Bridge story is the place it started: in orbit. In February 2025, Auxilium introduced that it had efficiently manufactured the implant aboard the ISS utilizing its AMP-1 bioprinter. The printer was constructed to function in microgravity, which permits for larger precision and extra advanced buildings than can typically be achieved on Earth.
By printing in area, the corporate was in a position to create implants with extraordinarily advantageous particulars, just like the microchannels that assist nerves develop again correctly, with out the chance of structural collapse attributable to gravity.
AMP-1 bioprinter. Picture courtesy of Auxilium Biotechnologies.
The AMP-1 bioprinter makes use of small, preloaded cartridges with organic supplies, taking lower than a minute of astronaut time per session. The printed implants are then despatched again to Earth to be used in trials like Neurospan-1.
āThis represents a leap in technological innovation,ā stated Isac Lazarovits, Director of Engineering at Auxilium. āWith AMP-1 now operational, we’re advancing our biomanufacturing analysis and the event of regenerative medical units at an unprecedented tempo.ā
Auxilium Biotechnologies 3D bioprinted eight implantable medical units for repairing nerve harm aboard the ISS. Picture courtesy of Enterprise Wire.
Why Area Bioprinting Issues
Bioprinting in area presents actual manufacturing advantages, particularly for implants made out of comfortable, residing, or advanced biomaterials. In response to the researchers, microgravity lets supplies settle extra evenly, serving to create higher shapes, extra secure buildings, and extra dependable efficiency within the physique.
This might open the door to new therapies for accidents that beforehand had restricted choices. For now, the printed implants might be used on Earth, however the identical know-how could sometime assist astronauts recuperate from accidents throughout lengthy missions to the Moon or Mars.
Auxiliumās success additionally reveals how space-based manufacturing, as soon as the area of huge aerospace corporations, has turn out to be extra accessible to smaller biotech corporations targeted on fixing real-world medical issues.
Auxilium Biotechnologies 3D bio-printed perfusable vasculature aboard the ISS, demonstrating the power to print blood vessels. Picture courtesy of Enterprise Wire.
With the trial underway, the main focus now’s on the outcomes. Auxilium hopes to show that the NeuroSpan Bridge may also help sufferers recuperate sooner and with fewer long-term issues than with conventional grafts or nerve restore methods.
In the meantime, the corporate can be trying on the sustainability facet of this. Because the NeuroSpan Bridge is made out of metal-based supplies, any leftover powder from the printing course of is distributed again to Auxiliumās associate, International Superior Metals, for recycling. This creates a full closed-loop system, decreasing waste and making manufacturing extra sustainable.
General, Auxiliumās trial proves that what began in orbit is now being examined on sufferers, marking a serious step for space-based bioprinting in real-world drugs.
Subscribe to Our E-mail E-newsletter
Keep up-to-date on all the most recent information from the 3D printing business and obtain info and presents from third celebration distributors.
Add your 3D Fashions and get them printed rapidly and effectively.
